Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,631 | -6,557 | -11,911 | -14,850 | -14,145 |
| Depreciation Amortization | 58 | 69 | 68 | 58 | 45 |
| Accounts payable and accrued liabilities | 159 | -130 | 129 | -711 | 841 |
| Other Working Capital | 763 | -670 | 635 | -1,768 | 1,594 |
| Other Operating Activity | 1,137 | 2,518 | 2,842 | 5,037 | 2,612 |
| Operating Cash Flow | $-2,514 | $-4,770 | $-8,237 | $-12,234 | $-9,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,101 | -2,091 | 3 |
| PPE Investments | -18 | N/A | N/A | -75 | -195 |
| Investing Cash Flow | $-18 | $N/A | $2,101 | $-2,166 | $-192 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,866 | 14,098 | N/A | N/A | N/A |
| Other Financing Activity | -60 | 0 | 0 | -284 | -46 |
| Financing Cash Flow | $5,806 | $14,098 | $N/A | $-284 | $-46 |
| Beginning Cash Position | 19,807 | 10,479 | 16,615 | 31,299 | 40,590 |
| End Cash Position | 23,081 | 19,807 | 10,479 | 16,615 | 31,299 |
| Net Cash Flow | $3,274 | $9,328 | $-6,136 | $-14,684 | $-9,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,514 | -4,770 | -8,237 | -12,234 | -9,053 |
| Capital Expenditure | -18 | N/A | N/A | -75 | -195 |
| Free Cash Flow | -2,532 | -4,770 | -8,237 | -12,309 | -9,248 |